| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,500,000 |
| Market
Cap: |
1.95(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$35.77 - $65 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
32,136 |
465,065 |
655,744 |
1,062,982 |
| Total Sell Value |
$1,503,716 |
$26,033,932 |
$35,438,128 |
$50,015,597 |
| Total People Sold |
3 |
7 |
9 |
11 |
| Total Sell Transactions |
5 |
17 |
34 |
71 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Peters William J |
CFO, EVP & Treasurer |
• – – |
2022-02-08 |
4 |
AS |
$26.95 |
$269,500 |
D/D |
(10,000) |
106,042 |
|
19% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2022-02-08 |
4 |
OE |
$14.95 |
$149,500 |
D/D |
10,000 |
116,042 |
|
- |
|
| Zhou Rong |
EVP, Production Center |
• – – |
2022-02-08 |
4 |
AS |
$26.77 |
$187,390 |
D/D |
(7,000) |
76,553 |
|
19% |
|
| Zhou Rong |
EVP, Production Center |
• – – |
2022-02-08 |
4 |
OE |
$10.93 |
$76,510 |
D/D |
7,000 |
83,553 |
|
- |
|
| Petersen Floyd F. |
Director |
– • – |
2022-02-01 |
4 |
AS |
$23.37 |
$12,041 |
D/D |
(500) |
77,373 |
|
22% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2022-01-10 |
4 |
AS |
$25.40 |
$406,400 |
D/D |
(16,000) |
106,042 |
|
30% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2022-01-10 |
4 |
OE |
$14.40 |
$230,400 |
D/D |
16,000 |
122,042 |
|
- |
|
| Zhou Rong |
EVP, Production Center |
• – – |
2022-01-10 |
4 |
AS |
$24.96 |
$530,684 |
D/D |
(20,928) |
76,553 |
|
30% |
|
| Zhou Rong |
EVP, Production Center |
• – – |
2022-01-10 |
4 |
OE |
$10.93 |
$153,020 |
D/D |
14,000 |
97,481 |
|
- |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2022-01-07 |
4 |
AS |
$24.15 |
$776,222 |
D/D |
(31,776) |
106,042 |
|
36% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2022-01-07 |
4 |
OE |
$14.40 |
$457,574 |
D/D |
31,776 |
137,818 |
|
- |
|
| Petersen Floyd F. |
Director |
– • – |
2022-01-03 |
4 |
AS |
$23.22 |
$11,609 |
D/D |
(500) |
77,873 |
|
51% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2021-12-30 |
4 |
AS |
$23.40 |
$234,000 |
D/D |
(10,000) |
106,042 |
|
47% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2021-12-30 |
4 |
OE |
$14.40 |
$144,000 |
D/D |
10,000 |
116,042 |
|
- |
|
| Petersen Floyd F. |
Director |
– • – |
2021-12-22 |
4 |
AS |
$22.50 |
$22,503 |
D/D |
(1,000) |
78,373 |
|
55% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2021-12-21 |
4 |
AS |
$22.40 |
$184,934 |
D/D |
(8,256) |
106,042 |
|
59% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2021-12-21 |
4 |
OE |
$14.40 |
$118,886 |
D/D |
8,256 |
114,298 |
|
- |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2021-12-16 |
4 |
AS |
$22.40 |
$39,066 |
D/D |
(1,744) |
106,042 |
|
64% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2021-12-16 |
4 |
OE |
$14.40 |
$25,114 |
D/D |
1,744 |
107,786 |
|
- |
|
| Prins Richard K |
Director |
– • – |
2021-12-10 |
4 |
S |
$21.36 |
$113,006 |
D/D |
(5,291) |
45,179 |
|
-74% |
|
| Prins Richard K |
Director |
– • – |
2021-12-10 |
4 |
OE |
$17.11 |
$90,529 |
D/D |
5,291 |
50,470 |
|
- |
|
| Zhou Rong |
EVP, Production Center |
• – – |
2021-11-11 |
4 |
AS |
$21.67 |
$169,308 |
D/D |
(7,813) |
83,121 |
|
72% |
|
| Zhou Rong |
EVP, Production Center |
• – – |
2021-11-11 |
4 |
OE |
$10.48 |
$81,880 |
D/D |
7,813 |
90,934 |
|
- |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2021-11-11 |
4 |
AS |
$21.33 |
$213,300 |
D/D |
(10,000) |
105,689 |
|
72% |
|
| Peters William J |
CFO, EVP & Treasurer |
• – – |
2021-11-11 |
4 |
OE |
$11.33 |
$113,300 |
D/D |
10,000 |
115,689 |
|
- |
|
954 Records found
|
|
Page 9 of 39 |
|
|
0.28 (0.69%) 
